Cleared Traditional

K062303 - FRAXEL II SR LASER SYSTEM

K062303 is an FDA 510(k) clearance for FRAXEL II SR LASER SYSTEM, manufactured by Reliant Technologies, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 176-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2007
Decision
176d
Days
Class 2
Risk

K062303 is an FDA 510(k) clearance for the FRAXEL II SR LASER SYSTEM. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Reliant Technologies, Inc. (Mountain View, US). The FDA issued a Cleared decision on January 31, 2007 after a review of 176 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Reliant Technologies, Inc. devices

FDA 510(k) Submission Details - K062303

510(k) Number K062303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 2006
Decision Date January 31, 2007
Days to Decision 176 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 115d · This submission: 176d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1639
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K062303.
PALOMAR LUX1540 HANDPIECE
K061652 · Palomar Medical Products, Inc. · Feb 2007
PALOMAR LUX2940 HANDPIECE
K063571 · Palomar Medical Technologies, Inc. · Feb 2007
CANDELA FLUORESCENT PULSED LIGHT SYSTEM
K063800 · Candela Corp. · Feb 2007
YAG MIR II LASER
K070063 · Cynosure, Inc. · Jan 2007
EZLASE
K061898 · Biolase Technology, Inc. · Jan 2007
CANDELA 3630 LASER SYSTEM
K063074 · Candela Corp. · Dec 2006